North Carolina's Pharma/Biotech Capital Construction Project Activity Remains Strong, an Industrial Info Market Brief
North Carolina's Pharma/Biotech Capital Construction Project Activity Remains Strong, an Industrial Info Market Brief
Attachment: Map
North Carolina continues to see a surge of Pharmaceutical/Biotech construction activity. Major firms such as Merck, Eli Lilly, Pfizer and Grifols are either planting or expanding their manufacturing roots in the state. North Carolina's attraction can be attributed to its skilled workforce, state/local incentives, and proximity to other pharma/biotech firms.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021